Bylvay is a medicine for treating patients from the age of 6 months with progressive familial intrahepatic cholestasis (PFIC), a rare type of liver disease in which bile acids build up in the liver. Bile acids are a component of bile, a fluid produced in the liver that helps to absorb fats from the gut. Bylvay contains the active substance odevixibat.
Therapeutic Indication
### Therapeutic indication Bylvay is indicated for the treatment of progressive familial intrahepatic cholestasis (PFIC) in patients aged 6 months or older (see sections 4.4 and 5.1).
Therapeutic Area (MeSH)
ATC Code
A05AX
ATC Item
胆病的其它治疗药
Pharmacotherapeutic Group
Bile and liver therapy
Active Substance (Summary)
INN / Common Names
EMA Name
Bylvay
Medicine Name
Bylvay
Aliases
N/ANo risk management plan link.
